Clinical Trial Update: Pharmacological Modulations of Allergen-Specific Immunotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial update on pharmacological modulations of allergen-specific immunotherapy for asthma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Medical University of Lodz | Conditions: Asthma | Phase 3 | Status: COMPLETED